Tenet Healthcare (THC) Stock Drops Despite Market Gains: Important Facts to Note

Tenet Healthcare (THC) closed the latest trading day at $156.56, indicating a -5.79% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.55%. Elsewhere, the Dow saw an upswing of 0.25%, while the tech-heavy Nasdaq appreciated by 0.63%.The the stock of hospital operator has risen by 7.52% in the past month, leading the Medical sector's gain of 3.49% and the S&P 500's gain of 6.29%.The investment community will be paying close attention to the earnings performance of Tenet Healthcare in its upcoming release. In that report, analysts expect Tenet Healthcare to post earnings of $2.84 per share. This would mark year-over-year growth of 22.94%. Meanwhile, the latest consensus estimate predicts the revenue to be $5.15 billion, indicating a 0.85% increase compared to the same quarter of the previous year.Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $12.72 per share and revenue of $20.9 billion. These totals would mark changes of +7.07% and +1.12%, respectively, from last year.Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Tenet Healthcare. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 0.09% downward. Tenet Healthcare is holding a Zacks Rank of #3 (Hold) right now.Valuation is also important, so investors should note that Tenet Healthcare has a Forward P/E ratio of 13.06 right now. This indicates a premium in contrast to its industry's Forward P/E of 11.12.Also, we should mention that THC has a PEG ratio of 1.21. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Medical - Hospital was holding an average PEG ratio of 1.25 at yesterday's closing price.The Medical - Hospital industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 93, which puts it in the top 38% of all 250+ industries.The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tenet Healthcare Corporation (THC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks